KEGG   PATHWAY: lma00020
Entry
lma00020                    Pathway                                
Name
Citrate cycle (TCA cycle) - Leishmania major
Description
The citrate cycle (TCA cycle, Krebs cycle) is an important aerobic pathway for the final steps of the oxidation of carbohydrates and fatty acids. The cycle starts with acetyl-CoA, the activated form of acetate, derived from glycolysis and pyruvate oxidation for carbohydrates and from beta oxidation of fatty acids. The two-carbon acetyl group in acetyl-CoA is transferred to the four-carbon compound of oxaloacetate to form the six-carbon compound of citrate. In a series of reactions two carbons in citrate are oxidized to CO2 and the reaction pathway supplies NADH for use in the oxidative phosphorylation and other metabolic processes. The pathway also supplies important precursor metabolites including 2-oxoglutarate. At the end of the cycle the remaining four-carbon part is transformed back to oxaloacetate. According to the genome sequence data, many organisms seem to lack genes for the full cycle [MD:M00009], but contain genes for specific segments [MD:M00010 M00011].
Class
Metabolism; Carbohydrate metabolism
Pathway map
lma00020  Citrate cycle (TCA cycle)
lma00020

Module
lma_M00003  Gluconeogenesis, oxaloacetate => fructose-6P [PATH:lma00020]
lma_M00010  Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate [PATH:lma00020]
lma_M00307  Pyruvate oxidation, pyruvate => acetyl-CoA [PATH:lma00020]
Other DBs
GO: 0006099
Organism
Leishmania major [GN:lma]
Gene
LMJF_18_0680  putative citrate synthase [KO:K01647] [EC:2.3.3.1]
LMJF_18_0670  putative citrate synthase [KO:K01647] [EC:2.3.3.1]
LMJF_18_0510  putative aconitase [KO:K01681] [EC:4.2.1.3]
LMJF_10_0290  putative isocitrate dehydrogenase [NADP] mitochondrial precursor [KO:K00031] [EC:1.1.1.42]
LMJF_33_2550  putative isocitrate dehydrogenase [KO:K00031] [EC:1.1.1.42]
LMJF_36_3470  putative 2-oxoglutarate dehydrogenase E1 component [KO:K00164] [EC:1.2.4.2]
LMJF_27_0880  putative 2-oxoglutarate dehydrogenase subunit [KO:K00164] [EC:1.2.4.2]
LMJF_28_2420  putative 2-oxoglutarate dehydrogenase,E2 component, dihydrolipoamide succinyltransferase [KO:K00658] [EC:2.3.1.61]
LMJF_31_2650  acetoin dehydrogenase E3 component-like protein [KO:K00382] [EC:1.8.1.4]
LMJF_32_3310  GCVL-2; putative dihydrolipoamide dehydrogenase [KO:K00382] [EC:1.8.1.4]
LMJF_31_2640  2-oxoglutarate dehydrogenase, E3 component,lipoamidedehydrogenase-like protein [KO:K00382] [EC:1.8.1.4]
LMJF_29_1830  GCVL-1; putative dihydrolipoamide dehydrogenase [KO:K00382] [EC:1.8.1.4]
LMJF_25_2140  putative succinyl-CoA synthetase alpha subunit [KO:K01899] [EC:6.2.1.4 6.2.1.5]
LMJF_25_2130  putative succinyl-CoA synthetase alpha subunit [KO:K01899] [EC:6.2.1.4 6.2.1.5]
LMJF_36_2950  putative succinyl-CoA ligase [GDP-forming] beta-chain [KO:K01900] [EC:6.2.1.4 6.2.1.5]
LMJF_24_1630  putative succinate dehydrogenase flavoprotein [KO:K00234] [EC:1.3.5.1]
LMJF_24_0320  putative fumarate hydratase [KO:K01676] [EC:4.2.1.2]
LMJF_29_1960  putative fumarate hydratase [KO:K01676] [EC:4.2.1.2]
LMJF_28_2860  cMDH; cytosolic malate dehydrogenase [KO:K00025] [EC:1.1.1.37]
LMJF_34_0160  mMDH; mitochondrial malate dehydrogenase [KO:K00026] [EC:1.1.1.37]
LMJF_34_0140  malate dehydrogenase [KO:K00026] [EC:1.1.1.37]
LMJF_34_0130  putative malate dehydrogenase [KO:K00026] [EC:1.1.1.37]
LMJF_19_0710  gMDH; glycosomal malate dehydrogenase [KO:K00026] [EC:1.1.1.37]
LMJF_34_0150  putative malate dehydrogenase [KO:K00026] [EC:1.1.1.37]
LMJF_27_1805  putative glycosomal phosphoenolpyruvate carboxykinase [KO:K01610] [EC:4.1.1.49]
LMJF_27_1810  putative glycosomal phosphoenolpyruvate carboxykinase [KO:K01610] [EC:4.1.1.49]
LMJF_18_1380  putative pyruvate dehydrogenase E1 component alpha subunit [KO:K00161] [EC:1.2.4.1]
LMJF_25_1710  putative pyruvate dehydrogenase E1 beta subunit [KO:K00162] [EC:1.2.4.1]
LMJF_21_0550  dihydrolipoamide acetyltransferase precursorlike protein [KO:K00627] [EC:2.3.1.12]
LMJF_36_2660  putative dihydrolipoamide acetyltransferase precursor [KO:K00627] [EC:2.3.1.12]
Compound
C00022  Pyruvate
C00024  Acetyl-CoA
C00026  2-Oxoglutarate
C00036  Oxaloacetate
C00042  Succinate
C00068  Thiamin diphosphate
C00074  Phosphoenolpyruvate
C00091  Succinyl-CoA
C00122  Fumarate
C00149  (S)-Malate
C00158  Citrate
C00311  Isocitrate
C00417  cis-Aconitate
C05125  2-(alpha-Hydroxyethyl)thiamine diphosphate
C05379  Oxalosuccinate
C05381  3-Carboxy-1-hydroxypropyl-ThPP
C15972  Enzyme N6-(lipoyl)lysine
C15973  Enzyme N6-(dihydrolipoyl)lysine
C16254  [Dihydrolipoyllysine-residue succinyltransferase] S-succinyldihydrolipoyllysine
C16255  [Dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine
Reference
  Authors
Nishizuka Y (ed).
  Title
[Metabolic Maps] (In Japanese)
  Journal
Tokyo Kagaku Dojin (1980)
Reference
  Authors
Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).
  Title
[Cellular Functions and Metabolic Maps] (In Japanese)
  Journal
Tokyo Kagaku Dojin (1997)
Reference
  Authors
Michal G.
  Title
Biochemical Pathways
  Journal
Wiley (1999)
Related
pathway
lma00010  Glycolysis / Gluconeogenesis
lma00053  Ascorbate and aldarate metabolism
lma00061  Fatty acid biosynthesis
lma00062  Fatty acid elongation
lma00071  Fatty acid degradation
lma00190  Oxidative phosphorylation
lma00220  Arginine biosynthesis
lma00250  Alanine, aspartate and glutamate metabolism
lma00280  Valine, leucine and isoleucine degradation
lma00350  Tyrosine metabolism
lma00630  Glyoxylate and dicarboxylate metabolism
KO pathway
ko00020   
LinkDB

DBGET integrated database retrieval system